Evoke Pharma Inc (EVOK)
0.432
-0.02
(-3.46%)
USD |
NASDAQ |
Apr 25, 10:01
Evoke Pharma Total Assets (Quarterly): 7.068M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 7.068M |
| September 30, 2023 | 7.853M |
| June 30, 2023 | 8.980M |
| March 31, 2023 | 10.04M |
| December 31, 2022 | 11.85M |
| September 30, 2022 | 13.41M |
| June 30, 2022 | 14.40M |
| March 31, 2022 | 9.026M |
| December 31, 2021 | 10.57M |
| September 30, 2021 | 11.65M |
| June 30, 2021 | 17.56M |
| March 31, 2021 | 19.30M |
| December 31, 2020 | 9.434M |
| September 30, 2020 | 6.751M |
| June 30, 2020 | 8.267M |
| March 31, 2020 | 4.638M |
| December 31, 2019 | 6.396M |
| September 30, 2019 | 7.327M |
| June 30, 2019 | 7.631M |
| March 31, 2019 | 4.363M |
| December 31, 2018 | 5.660M |
| September 30, 2018 | 7.018M |
| June 30, 2018 | 6.626M |
| Date | Value |
|---|---|
| March 31, 2018 | 5.585M |
| December 31, 2017 | 7.942M |
| September 30, 2017 | 10.76M |
| June 30, 2017 | 13.16M |
| March 31, 2017 | 14.84M |
| December 31, 2016 | 9.294M |
| September 30, 2016 | 10.81M |
| June 30, 2016 | 4.636M |
| March 31, 2016 | 6.872M |
| December 31, 2015 | 9.532M |
| September 30, 2015 | 11.68M |
| June 30, 2015 | 10.61M |
| March 31, 2015 | 12.62M |
| December 31, 2014 | 15.23M |
| September 30, 2014 | 13.39M |
| June 30, 2014 | 17.02M |
| March 31, 2014 | 22.57M |
| December 31, 2013 | 24.99M |
| September 30, 2013 | 23.74M |
| June 30, 2013 | |
| March 31, 2013 | 0.00 |
| December 31, 2012 | 0.116M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
4.638M
Minimum
Mar 2020
19.30M
Maximum
Mar 2021
10.11M
Average
9.026M
Median
Mar 2022
Total Assets (Quarterly) Benchmarks
| Eton Pharmaceuticals Inc | 31.74M |
| NovaBay Pharmaceuticals Inc | 9.034M |
| Palatin Technologies Inc | 13.55M |
| iBio Inc | 34.02M |
| Theriva Biologics Inc | 55.22M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 9.648M |
| Shareholders Equity (Quarterly) | -2.580M |
| Debt to Equity Ratio | -1.938 |
| Current Ratio | 2.249 |